Syneos Health Inc SYNH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
83.47UNCH (UNCH)
Volume
11,663
Close
83.47quote price arrow down-0.25 (-0.30%)
Volume
561,031
52 week range
50.27 - 90.10

...

Loading . . .
  • Open83.99
  • Day High84.26
  • Day Low83.29
  • Prev Close83.72
  • 52 Week High90.10
  • 52 Week High Date05/25/21
  • 52 Week Low50.27
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap8.705B
  • Shares Out104.29M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.83
  • YTD % Change22.52

KEY STATS

  • Open83.99
  • Day High84.26
  • Day Low83.29
  • Prev Close83.72
  • 52 Week High90.10
  • 52 Week High Date05/25/21
  • 52 Week Low50.27
  • 52 Week Low Date09/24/20
  • Market Cap8.705B
  • Shares Out104.29M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.83
  • YTD % Change22.52

RATIOS/PROFITABILITY

  • EPS (TTM)1.88
  • P/E (TTM)44.48
  • Fwd P/E (NTM)18.52
  • EBITDA (MRQ)579.961M
  • ROE (MRQ)6.37%
  • Revenue (MRQ)4.461B
  • Gross Margin (MRQ)23.35%
  • Net Margin (MRQ)4.44%
  • Debt To Equity (MRQ)89.82%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Syneos Health Inc

There is no recent news for this security.

Profile

MORE
Syneos Health Inc. is a fully integrated biopharmaceutical solutions providing company. The Company offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It brings together approximately 24,000 clinical and commercial professionals with the...
John Dineen
Chairman
Alistair Macdonald
Chief Executive Officer
Jason Meggs
Chief Financial Officer
Jonathan Olefson J.D.
General Counsel
Address
1030 Sync Street
Morrisville, NC
27560
United States

Top Peers

SYMBOLLASTCHG%CHG
GRFS
Grifols SA
18.40-0.30-1.60%
PRAH
PRA Health Sciences Inc
168.10-0.56-0.33%
CRL
Charles River Laboratories International Inc
355.33+3.24+0.92%
INCY
Incyte Corp
82.64+0.06+0.07%
EBS
Emergent BioSolutions Inc
61.79-1.72-2.71%